FDA Grants Breakthrough Device Designation to Tempus’ Atrial Fibrillation ECG Analysis Platform, Developed in Collaboration With Geisinger

March 24, 2021 12:00 UTC

Trending Today

Global shares jump as markets cheer US inflation surprise

The only way I could afford to come back to Dublin is if the Irish Government hired me for a very specific role – The Irish Times

Inside Tommy Robinson’s world: Leader of Britain’s right-wing nationalist upsurge

Government unlikely to hit its housing targets, Central Bank says

FDA Grants Breakthrough Device Designation to Tempus’ Atrial Fibrillation ECG Analysis Platform, Developed in Collaboration With Geisinger

You will receive full, ad-free access to HeraldChronicle.com as well as full access to the Electronic Edition of the newspaper. ONLY $2.99 per month for the first 3 months! Only $3.99 per month after promotional period. OrONLY $33.99 per year for the 1st yearOnly $37.99 per year after promotional period.

Source: The Herald March 24, 2021 12:00 UTC

Ryanair boss says face masks likely to be mandatory until spring 2022 on its flights

Love Island's Malin Andersson displays her curves in sheer lace lingerie

Couple recreate wedding photos exactly 50 years later at same church